Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $29,679,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 196 grants at over 100 hospitals in 29 countries.
Emory University Hospital – $100,000
$100,000.00 USD
December 2025
Sumoylation as a Novel Therapeutic Target in DIPG
Children’s Hospital Colorado – $99,974
$99,974.00 USD
December 2025
A Diffuse Midline Glioma Combination/Multimodality Clinical Trial and Investigation
Emory University Hospital – $200,000
$200,000.00 USD
December 2025
Advancing T Cell Therapy for DMG Using Tumor-Directed Gamma Delta T Cells and TLR7/8 Agonist Immunomodulation
University of Alabama at Birmingham Hospital – $200,000
$200,000.00 USD
December 2025
Intranasal Delivery of Oncolytic Virus in DMG
Johns Hopkins University School of Medicine – $99,000
$99,000.00 USD
December 2025
Proinflammatory Myeloid Cells with GD2.CAR as Immunotherapy for High Grade Gliomas, Including Pediatric Diffuse Midline Gliomas
Johns Hopkins University School of Medicine – $100,000
$100,000.00 USD
December 2025
Imaging of DMG Stem Cells Using Mannose-Weighted CEST MRI
Children's National Medical Center – $200,000
$200,000.00 USD
December 2025
“Targeted and Tuned: GPNMB/B7H3 Dual-Targeting CAR T-Cells With Focused Ultrasound for Potent Immunotherapy in Pediatric Gliomas
Children's National Medical Center – $200,000
$200,000.00 USD
December 2025
Multilamellar H3K27M RNA Aggregates Targeting Diffuse Midline Glioma
The International DIPG/DMG Registry – $1,405,679
$1,405,679.00 USD
November 2025
Years 2025-2028
Seattle Children’s Hospital – $1,000,000 (Installment 1 of 4)
$250,000.00 USD
September 2025
Augmentation of the tumor immune microenvironment to enhance B7-H3 CAR T cell efficacy against diffuse midline glioma
Princess Maxima Center – $50,000
$50,000.00 USD
July 2025
Monitoring Nanobody-Based B7H3 CAR-T Cell Behavior and Efficacy in Diffuse Midline Glioma
Johns Hopkins Hospital – $100,000
$100,000.00 USD
December 2024
Leveraging Epigenetic Alterations for Therapy of Diffuse Midline Glioma
CONNECT Consortium (TarGeT 2025) - $32,230 USD / $50,000 AUD
$32,230.00 USD
December 2024
TarGeT 2025
CONNECT Consortium (TarGeT 2026) - $32,230 USD / $50,000 AUD
$32,230.00 USD
December 2024
TarGeT 2026
CONNECT Consortium (TarGeT 2027) - $6,445 USD / $10,000 AUD
$6,445.00 USD
December 2024
TarGeT 2027